Article info

PDF

Extended report
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
  1. Correspondence to Dr A Strangfeld, Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum Berlin, ein Leibniz Institut, Charitéplatz 1, 10117 Berlin, Germany; strangfeld{at}drfz.de
View Full Text

Citation

Strangfeld A, Eveslage M, Schneider M, et al
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Publication history

  • Accepted June 13, 2011
  • First published July 25, 2011.
Online issue publication 
September 30, 2011

Article Versions

  • Web Only Data

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.